Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic
Musculoskeletal Care · 2024
DOI: 10.1002/msc.1958 ↗At a glance
Journal article in Musculoskeletal Care, 2024. Written by Alexandra Husivargova Theofanidis and 6 co-authors. Institution: Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University, Kosice, Slovakia. Major MEDLINE topics: Arthritis, Rheumatoid, COVID-19. Cited 1 times so far (Crossref); 39 references. Funded by: Agentúra na Podporu Vྭskumu a Vྭvoja/Slovak Research and Development Agency, Agentúra na Podporu Výskumu a Vývoja.
Abstract (original language)
Background
We aimed to assess the role of the COVID‐19 pandemic in the association of clinical, physical, and psychological factors with pain in Rheumatoid Arthritis (RA) patients.
Methods
We included 103 RA patients (81.6% females; mean age 56.1 ± 13.8 years). Patients filled out the VAS‐pain, GAD‐7, PHQ‐9, MFI‐20, and B‐IPQ. Paired sample t ‐tests, correlations, and multiple regression analyses were used to analyse the data.
Results
Our results showed significantly worsened pain in the data collected post‐pandemic ( p ≤ 0.05). Pre‐pandemic, the final regression models showed an association between functional disability ( β = 0.24; p ≤ 0.05), illness perception ( β = 0.34; p ≤ 0.05) and pain. In post‐pandemic models, significant associations were found between fatigue ( β = 0.33; p ≤ 0.01) and illness perception ( β = 0.36; p ≤ 0.01) with pain. Positive illness perception was able to alleviate the associations between fatigue and depression with pain before and after the pandemic.
Conclusion
Findings indicate that patients with RA may have been negatively affected by the COVID‐19 pandemic given their vulnerability. Even though pharmacological treatment was not interrupted, post‐pandemic results showed significantly higher levels of experienced pain. Therefore, in addition to biological therapy, non‐pharmacological interventions, including psychological support aimed at diminishing negative illness perception, may be beneficial in reducing RA‐related pain, especially when dealing with a crisis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Social and Behavioural Medicine, Faculty of Medicine, PJ Safarik University, Kosice, Slovakia.
- Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- 1st Department of Internal Medicine, Faculty of Medicine, PJ Safarik University and L. Pasteur University Hospital, Kosice, Slovakia.
- Department of Health Psychology and Technology, University of Twente, Enschede, The Netherlands.
ORCID profiles: Alexandra Husivargova Theofanidis, Vladimira Timkova, Zelmira Macejova, Dagmar Breznoscakova, Robbert Sanderman, Iveta Nagyova
Funding
- Agentúra na Podporu Vྭskumu a Vྭvoja/Slovak Research and Development Agency
- Agentúra na Podporu Výskumu a Vývoja
Cite
APA
Theofanidis, A. H., Timkova, V., Macejova, Z., Kotradyova, Z., Breznoscakova, D., Sanderman, R., & Nagyova, I. (2024). Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic. Musculoskeletal Care. https://doi.org/10.1002/msc.1958
Vancouver
Theofanidis AH, Timkova V, Macejova Z, Kotradyova Z, Breznoscakova D, Sanderman R, et al. Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic. Musculoskeletal Care. 2024. doi:10.1002/msc.1958
BibTeX
@article{Theofanidis2024,
author = {Theofanidis, Alexandra Husivargova and Timkova, Vladimira and Macejova, Zelmira and Kotradyova, Zuzana and Breznoscakova, Dagmar and Sanderman, Robbert and Nagyova, Iveta},
title = {Pain in Biologic‐Treated Rheumatoid Arthritis Patients: The Role of Illness Perception Before and After the COVID‐19 Pandemic},
journal = {Musculoskeletal Care},
year = {2024},
doi = {10.1002/msc.1958}
}
EUVIMED